MannKind Corporation
MNKD
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Společnost MannKind Corporation, biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci inhalovaných léčebných přípravků pro endokrinní a vzácná onemocnění plic ve Spojených státech. Přípravek nabízí Afrezza, inhalační inzulín užívaný ke zlepšení kontroly glykémie u dospělých s diabetem. Také podporuje Thyquidity u dospělých a pediatrických endokrinologů a dalších poskytovatelů zdravotní péče pro léčbu hypotyreózy. Společnost má licenční smlouvu a smlouvu o spolupráci se společností United Therapeutics Corporation. Má také dohodu s NRx Pharmaceuticals na vývoji suchého prášku přípravku ZYESAMI (aviptadil), syntetické formy lidského vazoaktivního střevního peptidu, který pomáhá chránit buňky před zánětlivými stavy. MannKind Corporation byla založena v roce 1991 a sídlí ve Westlake Village v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
403
Založení
2004-07-28
Podobné společnosti
$ 14.80
+ $ 0.19
$ 31.58
+ $ 0.15
$ 22.78
- $ 0.12
$ 28.27
+ $ 4.08
$ 27.09
+ $ 0.61
$ 3.89
- $ 0.03
$ 4.64
- $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 349.0 | 349.0 | 285.5 | 199.0 | 99.8 | 75.4 | 65.1 | 63.0 | 27.9 | 11.7 | 174.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| Cost of Revenues | 82.4 | 61.2 | 76.6 | 62.8 | 57.5 | 38.9 | 24.6 | 28.0 | 20.5 | 17.2 | 50.1 | 140.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 266.6 | 287.8 | 208.9 | 136.2 | 42.3 | 36.6 | 40.5 | 35.1 | 7.4 | -5.5 | 124.7 | -140.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 112.0 | 82.1 | 76.5 | 78.4 | 76.8 | 70.1 | 72.4 | 66.3 | 58.5 | 51.3 | |
| Cost of Revenues | 24.1 | 20.2 | 20.6 | 17.5 | 19.6 | 18.0 | 20.4 | 18.6 | 18.1 | 14.3 | |
| Gross Profit | 87.8 | 61.9 | 56.0 | 60.8 | 57.2 | 52.1 | 52.0 | 47.7 | 40.4 | 37.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 31.3 | 19.7 | 12.3 | 6.2 | 6.9 | 8.7 | 14.1 | 14.9 | 29.7 | 100.2 | 109.7 | 101.5 | 100.0 | 112.3 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 94.3 | 91.5 | 77.4 | 59.0 | 74.7 | 79.7 | 75.0 | 46.9 | 108.4 | 79.4 | 59.7 | 45.5 | 40.6 | 40.3 | |
| Depreciation & Amortization | 13.3 | 12.3 | 9.0 | 4.5 | 2.4 | -0.1 | 0.2 | 0.1 | 2.9 | 3.5 | 4.2 | 13.3 | 18.6 | 14.1 | 14.4 | 15.9 | 17.3 | |
| Total Operating Expenses | 227.9 | 249.0 | 136.3 | 125.6 | 111.2 | 90.1 | 65.3 | 81.6 | 88.4 | 88.9 | 59.6 | 204.2 | 179.6 | 169.4 | 147.0 | 140.6 | 152.6 | |
| Operating Income | 38.7 | 38.8 | 72.6 | 8.7 | -68.9 | -53.5 | -24.8 | -46.5 | -76.6 | -108.2 | 67.3 | -344.7 | -179.6 | -169.4 | -147.0 | -140.5 | -152.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.2 | 10.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.5 | 24.0 | ||
| Depreciation & Amortization | 5.3 | 2.8 | 2.6 | 2.7 | 2.7 | 2.6 | 2.1 | 1.7 | 1.6 | 1.4 | ||
| Total Operating Expenses | 95.5 | 43.2 | 50.7 | 38.5 | 30.7 | 39.3 | 35.4 | 30.9 | 29.8 | 34.0 | ||
| Operating Income | -7.7 | 18.8 | 5.3 | 22.3 | 26.5 | 12.8 | 16.6 | 16.7 | 10.6 | 5.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 10.2 | 0.0 | 12.6 | 6.2 | 2.5 | 0.1 | 0.2 | 1.0 | 0.5 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 37.3 | 13.8 | 38.0 | 25.2 | 24.8 | 16.6 | 9.5 | 10.9 | 9.4 | 13.3 | 18.5 | 24.1 | 20.4 | 21.5 | 21.6 | 21.8 | 17.4 | |
| Other Expense | -37.3 | -37.4 | -42.1 | -19.1 | -18.5 | -27.4 | -32.7 | -5.4 | 3.3 | -10.0 | 79.0 | -140.1 | 1.7 | -0.6 | -1.2 | 1.5 | -0.7 | |
| IBT | 1.4 | 1.4 | 30.5 | -10.4 | -87.4 | -80.9 | -57.5 | -51.9 | -86.7 | -117.3 | 125.7 | -368.4 | -198.4 | -191.5 | -169.8 | -160.8 | -170.6 | |
| Income Tax Expense | -4.5 | -4.5 | 2.9 | 1.6 | 24.8 | 10.9 | -0.2 | 7.8 | 0.2 | 0.1 | 13.7 | 12.2 | 3.5 | 6.8 | -0.4 | 5.9 | 0.7 | |
| Net Income | 5.9 | 5.9 | 27.6 | -11.9 | -112.2 | -91.8 | -57.2 | -59.7 | -87.0 | -117.3 | 125.7 | -368.4 | -198.4 | -191.5 | -169.4 | -160.8 | -170.6 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.8 | 2.6 | 1.8 | 2.0 | 2.8 | 3.2 | 3.2 | 3.4 | 1.7 | 1.6 | ||
| Interest Expense | 13.1 | 7.3 | 6.2 | 10.6 | 7.5 | 8.4 | 12.9 | 9.3 | 5.4 | 5.3 | ||
| Other Expense | -13.2 | -11.0 | -4.4 | -8.7 | -18.1 | 0.1 | -18.3 | -5.8 | -4.9 | -3.4 | ||
| IBT | -20.9 | 7.8 | 0.9 | 13.6 | 8.4 | 12.9 | -1.7 | 10.9 | 3.0 | 1.7 | ||
| Income Tax Expense | -5.0 | -0.2 | 0.3 | 0.5 | 1.0 | 1.3 | 0.3 | 0.3 | 1.6 | 5.6 | ||
| Net Income | -15.9 | 8.0 | 0.7 | 13.2 | 7.4 | 11.6 | -2.0 | 10.6 | 1.4 | 1.7 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.04 | $-0.44 | $-0.37 | $-0.26 | $-0.31 | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | $-3.20 | $-4.68 | $-6.60 | $-7.50 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.04 | $-0.44 | $-0.37 | $-0.26 | $-0.31 | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | $-3.20 | $-4.68 | $-6.60 | $-7.50 | |
| Shares Outstanding | 305.6 | 305.6 | 274.4 | 267.0 | 257.1 | 249.2 | 222.6 | 195.6 | 144.1 | 104.2 | 92.1 | 81.2 | 77.0 | 59.9 | 36.2 | 24.4 | 22.7 | |
| Diluted Shares Outstanding | 314.1 | 314.1 | 283.8 | 267.0 | 257.1 | 249.2 | 222.6 | 195.6 | 144.1 | 104.2 | 92.1 | 81.2 | 77.0 | 59.9 | 36.2 | 24.4 | 22.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | ||
| Shares Outstanding | 305.6 | 306.8 | 305.0 | 303.5 | 279.2 | 275.0 | 273.1 | 270.4 | 269.6 | 268.7 | ||
| Diluted Shares Outstanding | 314.1 | 311.6 | 311.5 | 320.9 | 290.6 | 284.7 | 273.1 | 324.7 | 323.9 | 268.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 96.6 | 46.3 | 238.5 | 69.8 | 124.2 | 67.0 | 29.9 | 71.2 | 43.9 | 22.9 | 59.1 | 120.8 | 70.8 | 61.8 | 2.7 | 66.1 | |
| Short Term Investments | 151.1 | 150.9 | 56.6 | 101.1 | 79.9 | 0.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 4.4 | |
| Total Cash & ST Investments | 247.8 | 197.3 | 295.1 | 170.8 | 204.1 | 67.0 | 49.9 | 71.2 | 43.9 | 22.9 | 59.1 | 120.8 | 70.8 | 61.8 | 3.2 | 70.4 | |
| Accounts Receivable | 24.1 | 11.8 | 14.9 | 16.8 | 5.0 | 4.2 | 3.5 | 4.0 | 2.8 | 30.9 | 0.0 | 50.4 | 0.3 | 0.5 | 0.5 | 0.7 | |
| Inventory | 24.8 | 27.9 | 28.5 | 21.8 | 7.2 | 5.0 | 4.2 | 3.6 | 2.7 | 2.3 | 13.5 | 9.7 | -0.3 | -0.5 | -0.5 | 0.0 | |
| Other Current Assets | 29.3 | 31.4 | 34.8 | 25.5 | 3.5 | 3.3 | 3.2 | 2.6 | 3.0 | 4.4 | 4.0 | 70.6 | 5.5 | 5.0 | 2.6 | 2.8 | |
| Total Current Assets | 325.9 | 268.3 | 373.4 | 234.9 | 219.7 | 79.5 | 60.8 | 81.9 | 57.2 | 77.5 | 76.7 | 201.2 | 76.3 | 66.8 | 5.8 | 74.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 127.4 | 57.0 | 47.3 | 46.3 | 62.4 | 96.6 | 193.3 | 238.5 | 83.0 | 86.2 | |
| Short Term Investments | 132.6 | 122.0 | 134.2 | 150.9 | 189.2 | 151.1 | 107.5 | 56.6 | 58.0 | 58.2 | |
| Total Cash & ST Investments | 260.0 | 179.0 | 181.5 | 197.3 | 251.6 | 247.8 | 300.7 | 295.1 | 141.0 | 144.3 | |
| Accounts Receivable | 18.9 | 27.1 | 28.9 | 11.8 | 18.2 | 23.3 | 19.9 | 14.9 | 21.8 | 27.8 | |
| Inventory | 27.0 | 28.5 | 28.9 | 27.9 | 26.7 | 24.8 | 26.4 | 28.5 | 27.1 | 25.3 | |
| Other Current Assets | 52.9 | 44.4 | 34.4 | 31.4 | 31.2 | 30.1 | 36.0 | 34.8 | 35.6 | 32.8 | |
| Total Current Assets | 358.8 | 279.0 | 273.7 | 268.3 | 327.7 | 325.9 | 383.1 | 373.4 | 225.6 | 230.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 89.2 | 85.4 | 88.9 | 45.1 | 36.6 | 25.9 | 26.8 | 25.6 | 26.9 | 28.9 | 48.7 | 192.1 | 176.6 | 184.0 | 193.0 | 202.4 | |
| Goodwill | 1.9 | 1.9 | 1.9 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 1.0 | 5.3 | 1.1 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 14.1 | 5.5 | 7.2 | 2.0 | 56.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 11.6 | 27.5 | 2.7 | 9.7 | 8.2 | 3.3 | 6.2 | 0.2 | 0.4 | 0.6 | 1.0 | 1.2 | 5.8 | 0.5 | 0.7 | 0.9 | |
| Total Long-Term Assets | 117.9 | 125.5 | 101.8 | 60.4 | 101.4 | 29.1 | 33.0 | 25.9 | 27.4 | 29.6 | 49.8 | 193.3 | 182.4 | 184.5 | 193.7 | 203.3 | |
| Total Assets | 443.8 | 393.8 | 475.2 | 295.3 | 321.2 | 108.6 | 93.7 | 107.7 | 84.6 | 107.1 | 126.4 | 394.4 | 258.6 | 251.3 | 199.6 | 277.3 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 93.9 | 83.0 | 83.8 | 85.4 | 85.3 | 85.1 | 83.6 | 88.9 | 80.4 | 69.5 | |
| Goodwill | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | |
| Intangible Assets | 5.1 | 5.2 | 5.2 | 5.3 | 5.3 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | |
| Long-Term Investments | 27.0 | 22.2 | 16.7 | 5.5 | 16.8 | 13.4 | 3.7 | 7.2 | 3.3 | 2.3 | |
| Other Long-Term Assets | 7.8 | 20.4 | 28.8 | 27.5 | 27.2 | 16.4 | 7.4 | 1.7 | 8.0 | 8.4 | |
| Total Long-Term Assets | 135.8 | 132.7 | 136.4 | 125.5 | 136.5 | 117.9 | 97.8 | 101.8 | 94.8 | 83.2 | |
| Total Assets | 494.6 | 411.7 | 410.1 | 393.8 | 464.2 | 443.8 | 480.9 | 475.2 | 320.3 | 313.4 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.6 | 6.8 | 9.6 | 11.1 | 7.0 | 5.6 | 4.8 | 5.4 | 7.0 | 3.3 | 15.6 | 7.4 | 3.9 | 4.6 | 4.6 | 3.3 | |
| Short-Term Debt | 13.1 | 0.0 | 32.0 | 9.6 | 7.0 | 4.1 | 5.0 | 11.3 | 52.7 | 71.3 | 74.6 | 172.4 | 102.3 | 114.4 | 0.0 | 0.0 | |
| Other Current Liabilities | 49.9 | 62.6 | 63.9 | 44.9 | 33.6 | 30.8 | 23.3 | 7.7 | 24.8 | 14.0 | 160.6 | 7.5 | 5.7 | 1.3 | 20.7 | 14.8 | |
| Current Liabilities | 80.0 | 81.8 | 104.1 | 67.3 | 48.3 | 73.7 | 65.6 | 75.2 | 87.6 | 92.1 | 268.3 | 403.4 | 127.8 | 144.8 | 25.4 | 18.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.3 | 10.3 | 5.0 | 6.8 | 6.4 | 9.6 | 7.1 | 9.6 | 16.8 | 17.1 | |
| Short-Term Debt | 49.0 | 36.2 | 36.1 | 0.0 | 0.0 | 0.0 | 20.0 | 32.0 | 20.0 | 31.6 | |
| Other Current Liabilities | 42.8 | 54.4 | 63.0 | 62.6 | 57.6 | 62.6 | 63.3 | 51.9 | 56.0 | 44.8 | |
| Current Liabilities | 109.1 | 111.8 | 115.9 | 81.8 | 72.1 | 80.0 | 99.9 | 104.1 | 96.4 | 97.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 227.6 | 47.7 | 346.9 | 373.3 | 375.8 | 119.4 | 116.4 | 91.2 | 104.1 | 77.2 | 139.5 | 49.5 | 148.0 | 217.2 | 487.8 | 444.7 | |
| Capital Leases | 97.6 | 11.6 | 98.2 | 5.3 | 1.0 | 1.2 | 2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 97.6 | 0.0 | 0.0 | 0.0 | 0.4 | 4.2 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 669.6 | 472.7 | 721.4 | 545.8 | 530.5 | 289.0 | 284.3 | 282.8 | 299.3 | 290.7 | 476.7 | 468.2 | 289.4 | 362.0 | 513.2 | 462.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 177.0 | 10.7 | 11.1 | 47.7 | 240.3 | 231.0 | 247.8 | 350.4 | 257.5 | 451.2 | |
| Capital Leases | 0.0 | 10.7 | 11.1 | 11.6 | 12.3 | 3.5 | 3.6 | 98.2 | 4.3 | 4.6 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 98.2 | 0.1 | 0.1 | |
| Total Liabilities | 539.2 | 466.7 | 468.8 | 472.7 | 674.1 | 669.6 | 710.8 | 721.4 | 572.1 | 573.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.7 | 3.0 | 2.7 | 2.6 | 2.5 | 2.4 | 2.1 | 1.9 | 1.2 | 4.8 | 4.3 | 4.1 | 3.7 | 2.9 | 1.3 | 1.3 | |
| Retained Earnings | -3,220.8 | -3,201.8 | -3,229.4 | -3,217.5 | -3,130.1 | -3,049.1 | -2,991.9 | -2,940.0 | -2,854.9 | -2,737.6 | -2,863.2 | -2,494.8 | -2,296.4 | -2,104.9 | -1,935.5 | -1,774.7 | |
| Comprehensive Income | 0.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Total Common Equity | -225.8 | -78.8 | -246.2 | -250.5 | -209.3 | -180.4 | -190.5 | -175.1 | -214.7 | -183.6 | -350.3 | -73.8 | -30.7 | -110.7 | -313.7 | -185.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 3.1 | 3.1 | 3.0 | 3.0 | 2.8 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | |
| Retained Earnings | -3,180.0 | -3,188.0 | -3,188.7 | -3,201.8 | -3,209.2 | -3,220.8 | -3,218.8 | -3,229.4 | -3,230.8 | -3,232.5 | |
| Comprehensive Income | 0.1 | 1.3 | 1.2 | 1.1 | 0.6 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | |
| Total Common Equity | -44.6 | -55.0 | -58.6 | -78.8 | -209.9 | -225.8 | -230.0 | -246.2 | -251.8 | -260.5 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 338.2 | 47.7 | 382.4 | 382.9 | 382.7 | 123.4 | 121.4 | 102.5 | 156.8 | 148.5 | 139.5 | 49.5 | 148.0 | 217.2 | 487.8 | 444.7 | |
| Book Value | -225.8 | -78.8 | -246.2 | -250.5 | -209.3 | -180.4 | -190.5 | -175.1 | -214.7 | -183.6 | -350.3 | -73.8 | -30.7 | -110.7 | -313.7 | -185.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -44.6 | -55.0 | -58.6 | -78.8 | -209.9 | -225.8 | -230.0 | -246.2 | -251.8 | -260.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 11.7 | 5.9 | 27.6 | -11.9 | -87.4 | -80.9 | -57.2 | -51.9 | -87.0 | -117.3 | 125.7 | -368.4 | -198.4 | -191.5 | -169.4 | -160.8 | -170.6 | |
| Depreciation & Amortization | 6.7 | 12.3 | 9.0 | 5.8 | 9.1 | 5.5 | 3.3 | 2.2 | 0.0 | 3.5 | 4.2 | 13.3 | 18.6 | 14.1 | 14.4 | 15.9 | 17.3 | |
| Stock-Based Compensation | 18.7 | 24.2 | 21.4 | 17.6 | 13.4 | 12.2 | 6.5 | 6.2 | 6.9 | 4.8 | 5.1 | 8.7 | 48.6 | 45.2 | 13.3 | 11.2 | 13.6 | |
| Change Working Capital | -0.6 | -86.3 | -36.5 | 14.6 | -24.1 | -17.7 | -9.8 | -12.4 | 36.7 | 27.6 | -139.3 | 41.0 | 133.8 | 2.7 | 13.3 | 9.9 | -9.6 | |
| Change In Accounts Receivable | 4.4 | -4.8 | 2.7 | 2.3 | -11.8 | -0.8 | -0.7 | 0.5 | -1.3 | -2.5 | -0.3 | 51.6 | -63.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -7.6 | -16.7 | -2.8 | -1.5 | 4.1 | 1.4 | 0.8 | -0.6 | -1.6 | 3.8 | -12.1 | 8.4 | 3.6 | -1.1 | 0.0 | 2.7 | -4.3 | |
| Change In Inventories | -2.3 | 10.4 | -3.2 | 4.6 | -5.7 | -4.1 | -1.3 | -0.6 | -3.2 | -3.3 | -2.3 | -26.4 | -9.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 39.3 | 67.2 | 21.0 | 7.9 | 8.2 | 6.6 | 18.4 | -28.0 | 5.7 | 3.7 | 5.8 | 67.8 | 0.0 | 0.0 | 6.5 | -160.8 | 0.0 | |
| Cash from Operations | 40.6 | 0.0 | 0.0 | 34.1 | -80.7 | -61.7 | -28.1 | -88.5 | -37.7 | -64.8 | -78.1 | -57.2 | 4.1 | -128.7 | -119.9 | -123.8 | -148.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -15.9 | 8.0 | 0.7 | 13.2 | 7.4 | 11.6 | -2.0 | 10.6 | 1.4 | 1.7 | |
| Depreciation & Amortization | 4.2 | 2.8 | 2.6 | 2.7 | 2.7 | 3.0 | 2.1 | 1.7 | 1.6 | 1.5 | |
| Stock-Based Compensation | 7.0 | 0.0 | 7.5 | 5.4 | 5.8 | 5.2 | 6.4 | 3.9 | 3.8 | 4.6 | |
| Change Working Capital | -72.1 | -0.8 | -11.5 | -30.3 | -4.2 | -2.7 | -10.4 | -14.2 | 10.2 | 13.8 | |
| Change In Accounts Receivable | 0.8 | 9.8 | 1.8 | -17.1 | 6.4 | 5.2 | -3.4 | -5.5 | 7.4 | 6.0 | |
| Change In Accounts Payable | -17.2 | -3.0 | 5.2 | -1.8 | 0.3 | 0.0 | 2.4 | -2.4 | -7.2 | -0.4 | |
| Change In Inventories | -10.6 | -1.8 | -4.2 | -1.5 | -3.2 | -2.2 | 1.1 | 1.1 | -2.3 | -2.1 | |
| Other Non-cash Items | 73.9 | 13.6 | 9.7 | 2.7 | 10.9 | -7.8 | 7.8 | 4.7 | 13.8 | -11.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.6 | 8.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -22.6 | -4.6 | -9.7 | -42.4 | -7.6 | -11.5 | -4.8 | -2.6 | -0.4 | 0.0 | -1.1 | -10.3 | -24.1 | -8.0 | -0.6 | -6.9 | -9.5 | |
| Acquisitions | 2.0 | -347.7 | 0.0 | 0.0 | -15.3 | -56.1 | -4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -240.1 | -157.8 | -273.8 | -79.1 | -79.5 | -199.1 | -16.0 | -45.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.2 | |
| Sales of Investment | 138.9 | 221.7 | 58.1 | 119.2 | 107.3 | 59.1 | 20.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 2.0 | |
| Other Investing Activities | -99.9 | 0.0 | 0.0 | 0.4 | 0.0 | 56.1 | 20.0 | -0.3 | 0.1 | 16.7 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| Cash from Investing | -123.1 | 0.0 | 0.0 | -2.0 | 4.9 | -151.5 | 15.2 | -22.8 | -0.2 | 16.7 | -1.1 | -10.2 | -24.1 | -8.0 | -0.6 | -2.9 | -11.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.0 | -1.1 | -1.1 | -0.3 | -2.9 | -1.4 | -3.0 | -2.4 | -5.9 | -11.4 | |
| Acquisitions | -347.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 0.0 | |
| Investments | -13.7 | -56.0 | -44.0 | -44.1 | -7.0 | 0.0 | -119.0 | -68.4 | -28.6 | -24.1 | |
| Sales of Investment | 71.5 | 42.0 | 51.4 | 50.4 | 58.1 | 0.0 | 66.8 | 22.0 | 26.6 | 23.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 0.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.9 | -11.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -189.0 | 0.0 | 0.0 | -6.9 | 0.0 | -51.2 | 0.0 | -56.3 | -5.0 | -4.0 | -5.0 | -65.1 | 0.0 | -115.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 144.1 | 47.7 | -334.7 | 6.3 | 0.2 | 310.5 | 2.0 | 75.2 | -49.3 | 12.3 | 14.0 | 155.1 | -98.4 | 45.7 | -270.6 | 43.2 | 444.7 | |
| Issuance of Common Stock | 5.3 | 0.0 | 0.0 | 6.9 | 19.8 | 2.0 | 23.7 | 3.2 | 70.5 | 61.6 | 50.9 | 68.7 | 40.1 | 52.4 | 167.7 | 10.9 | 17.0 | |
| Repurchase of Common Stock | -6.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -5.6 | 0.0 | 0.0 | 136.6 | 1.6 | 319.4 | 25.5 | 122.9 | -4.2 | 16.0 | -2.9 | 2.1 | 29.9 | 208.2 | 11.8 | 52.5 | 179.4 | |
| Cash from Financing | 93.7 | 0.0 | 0.0 | 136.6 | 21.4 | 270.3 | 49.9 | 69.9 | 61.3 | 73.6 | 43.0 | 5.7 | 70.1 | 145.7 | 179.6 | 63.4 | 196.4 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 141.0 | -1.7 | |
| Debt Issued | 226.0 | 179.1 | -0.4 | -0.4 | -192.6 | 9.2 | -36.8 | -114.6 | 245.8 | -104.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | 5.2 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | -2.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 141.7 | -0.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 10.5 | 28.6 | -191.4 | 168.7 | -54.4 | 57.0 | 36.9 | -41.5 | 23.3 | 25.5 | -36.2 | -61.8 | 50.1 | 9.0 | 59.2 | -63.4 | 36.0 | |
| Closing Cash Balance | 96.6 | 75.6 | 47.1 | 238.5 | 69.8 | 124.2 | 67.2 | 30.2 | 71.7 | 48.4 | 22.9 | 59.1 | 120.8 | 70.8 | 61.8 | 2.7 | 66.1 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -52.5 | 70.4 | 9.7 | 1.0 | -16.0 | -34.3 | -95.9 | -45.2 | 155.5 | -3.2 | |
| Closing Cash Balance | 75.6 | 127.4 | 57.7 | 48.1 | 47.1 | 63.1 | 97.4 | 193.3 | 238.5 | 83.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 18.0 | 13.7 | 32.8 | -8.3 | -88.3 | -73.2 | -32.9 | -91.0 | -38.1 | -64.8 | -79.2 | -67.5 | -20.0 | -136.7 | -120.5 | -130.7 | -158.2 | |
| Real Free Cash Flow | -0.7 | -10.5 | 11.5 | -26.0 | -101.7 | -85.4 | -39.4 | -97.3 | -44.9 | -69.6 | -84.4 | -76.2 | -68.6 | -181.9 | -133.8 | -141.9 | -171.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.0 | 22.4 | 7.8 | -6.7 | 19.7 | 7.9 | 0.9 | 4.3 | 15.8 | -2.7 | |
| Real Free Cash Flow | -16.9 | 22.4 | 0.3 | -12.1 | 13.9 | 2.7 | -5.6 | 0.4 | 11.9 | -7.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 60 | 3.9 | -1.4 |
| P/S | 5.6 | 4077 | 9.4 |
| P/B | -39.4 | -6.5 | 5.2 |
| P/FCF | 71.6 | -66.6 | -1.5 |
| Market cap | $1.6 | $1.3 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 45.7 % | 127 % | 0 % |
| Debt to Income | 3853.8 % | -83.5 % | 0 % |
| Debt to Free cash flow | -3562.8 % | -39.3 % | 0 % |
| Interest expense percentage | 96.4 % | -10 % | 44.7 % |
| Current ratio | 3.3 | 1.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -13.2 % | 52.4 % | 0 % |
| ROA | 1.2 % | -60.7 % | 0 % |
| CapEx to Revenue | 1.7 % | 1276.8 % | 0 % |
| RaD to Revenue | 0 % | 5219.1 % | 0 % |
| ROEM | 857,410.3 | 105979.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 75.2 % | 54.6 % | 68.7 % |
| Operating margin | 23.2 % | -10041.5 % | 35.5 % |
| Net margin | 9.3 % | -12958.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1.1 % | 0 % |
| Dividend payout percentage | 0 % | -6.9 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 311.6 mil | 147.6 mil |
| Employee count | 0.4 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
